相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-carcinogenic effects of sulforaphane in association with its apoptosis-inducing and anti-inflammatory properties in human cervical cancer cells
Chhavi Sharma et al.
CANCER EPIDEMIOLOGY (2011)
Sulforaphane Increases Drug-mediated Cytotoxicity Toward Cancer Stem-like Cells of Pancreas and Prostate
Georgios Kallifatidis et al.
MOLECULAR THERAPY (2011)
Molecular Targets of Dietary Phenethyl Isothiocyanate and Sulforaphane for Cancer Chemoprevention
Ka Lung Cheung et al.
AAPS JOURNAL (2010)
Withaferin A targets heat shock protein 90 in pancreatic cancer cells
Yanke Yu et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Synergistic Activity of Sorafenib and Sulforaphane Abolishes Pancreatic Cancer Stem Cell Characteristics
Vanessa Rausch et al.
CANCER RESEARCH (2010)
Sulforaphane, a Dietary Component of Broccoli/Broccoli Sprouts, Inhibits Breast Cancer Stem Cells
Yanyan Li et al.
CLINICAL CANCER RESEARCH (2010)
Sulforaphane Causes Epigenetic Repression of hTERT Expression in Human Breast Cancer Cell Lines
Syed M. Meeran et al.
PLOS ONE (2010)
Dietary agent, benzyl isothiocyanate inhibits signal transducer and activator of transcription 3 phosphorylation and collaborates with sulforaphane in the growth suppression of PANC-1 cancer cells
Brian Hutzen et al.
CANCER CELL INTERNATIONAL (2009)
Targeting CDC37 An alternative, kinase-directed strategy for disruption of oncogenic chaperoning
Jennifer R. Smith et al.
CELL CYCLE (2009)
17 AAG for HSP90 Inhibition in Cancer - From Bench to Bedside
Saad Z. Usmani et al.
CURRENT MOLECULAR MEDICINE (2009)
Sulforaphane: from chemoprevention to pancreatic cancer treatment?
Johanna W. Lampe
GUT (2009)
Characterization of Celastrol to Inhibit Hsp90 and Cdc37 Interaction
Tao Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6
Angela Gibbs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Recent Advances in Hsp90 Inhibitors as Antitumor Agents
S. Messaoudi et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2008)
Combination of rapamycin and 17-allylamino-17-demethoxygeldanamycin abrogates Akt activation and potentiates mTOR blockade in breast cancer cells
Matthew M. Roforth et al.
ANTI-CANCER DRUGS (2008)
An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models
Udai Banerji et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Multi-targeted prevention of cancer by sulforaphane
John D. Clarke et al.
CANCER LETTERS (2008)
Sulforaphane Enhances the Therapeutic Potential of TRAIL in Prostate Cancer Orthotopic Model through Regulation of Apoptosis, Metastasis, and Angiogenesis
Sharmila Shankar et al.
CLINICAL CANCER RESEARCH (2008)
Synergistic antipancreatic tumor effect by simultaneously targeting hypoxic cancer cells with HSP90 inhibitor and glycolysis inhibitor
Xianhua Cao et al.
CLINICAL CANCER RESEARCH (2008)
A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells
Tao Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Pancreatic carcinogenesis
Jan-Bart M. Koorstra et al.
PANCREATOLOGY (2008)
A new approach to managing intraductal papillary mucinous pancreatic neoplasms
Paula Ghaneh et al.
GUT (2007)
Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells
Maximilian Reichert et al.
CANCER RESEARCH (2007)
Molecular basis for chemoprevention by sulforaphane: a comprehensive review
N. Juge et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-κB-regulated gene products
Ajaikumar B. Kunnumakkara et al.
CANCER RESEARCH (2007)
Cancer statistics, 2007
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
Discovery and development of sulforaphane as a cancer chemopreventive phytochemical
Yuesheng Zhang et al.
ACTA PHARMACOLOGICA SINICA (2007)
Sulforaphane increases the efficacy of doxorubicin in mouse fibroblasts characterized by p53 mutations
Carmela Fimognari et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2006)
Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators
Haley Hieronymus et al.
CANCER CELL (2006)
The co-chaperone p23 arrests the Hsp90 ATPase cycle to trap client proteins
SH McLaughlin et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Safety, tolerance, and metabolism of broccoli sprout glucosinolates and isothiocyanates: A clinical phase I study
Theresa A. Shapiro et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2006)
Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People's Republic of China
TW Kensler et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1:: Role of 17-AAG hydroquinone in heat shock protein 90 inhibition.
WC Guo et al.
CANCER RESEARCH (2005)
Hsp90 and Cdc37 - a chaperone cancer conspiracy
LH Pearl
CURRENT OPINION IN GENETICS & DEVELOPMENT (2005)
Isothiocyanates as novel cytotoxic and cytostatic agents:: molecular pathway on human transformed and non-transformed cells
C Fimognari et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Therapeutic and diagnostic implications of Hsp90 activation
A Kamal et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo
N Petri et al.
DRUG METABOLISM AND DISPOSITION (2003)
Development of small molecule Hsp90 inhibitors: Utilizing both forward and reverse chemical genomics for drug identification
L Neckers
CURRENT MEDICINAL CHEMISTRY (2003)
Incidence, mechanism and prognostic value of activated AKT in pancreas cancer
MG Schlieman et al.
BRITISH JOURNAL OF CANCER (2003)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Quantitative determination of dithiocarbamates in human plasma, serum, erythrocytes and urine: pharmacokinetics of broccoli sprout isothiocyanates in humans
LX Ye et al.
CLINICA CHIMICA ACTA (2002)
分享论文
